FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

418374009: Product containing precisely dantron 5 milligram/1 milliliter and poloxamer 188 40 milligram/1 milliliter conventional release oral suspension (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3694430010 Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
3694431014 Product containing precisely dantron 5 milligram/1 milliliter and poloxamer 188 40 milligram/1 milliliter conventional release oral suspension (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3694433012 Danthron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension Is a Product containing dantron and poloxamer 188 (medicinal product) false Inferred relationship Some
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Dantron false Inferred relationship Some
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension Has manufactured dose form Oral suspension true Inferred relationship Some
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Poloxamer 188 (substance) false Inferred relationship Some
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension Is a Product manufactured as oral dose form (product) false Inferred relationship Some
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension Is a Dantron- and poloxamer 188-containing product in oral dose form false Inferred relationship Some
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension Has concentration strength denominator value un false Inferred relationship Some 2
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension This attribute specifies the denominator unit for the concentration strength of a product. mL true Inferred relationship Some 1
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension This attribute specifies the numerator unit for the concentration strength of a product. mg true Inferred relationship Some 1
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension Has concentration strength denominator value un false Inferred relationship Some 1
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension This attribute specifies the denominator unit for the concentration strength of a product. mL true Inferred relationship Some 2
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension Count of base of active ingredient deux false Inferred relationship Some
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension This attribute specifies the numerator unit for the concentration strength of a product. mg true Inferred relationship Some 2
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Poloxamer 188 (substance) true Inferred relationship Some 2
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Dantron true Inferred relationship Some 1
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Poloxamer 188 (substance) true Inferred relationship Some 2
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension Has concentration strength numerator value 40 false Inferred relationship Some 2
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Dantron true Inferred relationship Some 1
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension Has concentration strength numerator value cinq false Inferred relationship Some 1
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension Plays role Laxative therapeutic role false Inferred relationship Some
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension Plays role Stool softener therapeutic role false Inferred relationship Some
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension Is a Dantron and poloxamer 188 only product in oral dose form true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start